Sign in Subscribe

Michelle Whirl-Carrillo, PhD

PharmGKB Director and Co-PI

Recent Updates to PharmGKB’s Genotype Selection Interface (GSI) Tool

We are excited to announce that we have partnered with Dr. Emily Cicali on behalf of The University of Florida Health Precision Medicine Program to incorporate the information presented in the PROPTM pharmacogenetics calculator into the GSI. Users can select from a list of concomitant medications that are either strong

PharmGKB is the Global Core Biodata Resource (GCBR) of the week

Since June 2024, the GCBR of the Week campaign highlights a Global Core Biodata Resource via social media. We are happy to announce that this week, GCBR profiles PharmGKB on LinkedIn and X as part of their series.

Updated PharmVar CYP1A2 Nomenclature

From Andrea Gaedigk and Pablo Zubiaur on behalf of the CYP1A2 PharmVar expert panel PharmVar now provides expert panel curated nomenclature for CYP1A2. Before Dec 16, 2024, PharmVar displayed the legacy content of the former Human Cytochrome P450 Nomenclature Database which was updated for the last time in 2007. This

AMP Survey on PGx Genotyping Recommendations

The Association for Molecular Pathology (AMP) Pharmacogenomics Working Group has launched a survey that is designed to understand the impact and evaluate the implementation of their series of recommendations on clinical PGx testing. The survey is designed to capture individual responses from molecular laboratory professionals currently performing, planning to perform,

Save the Date for ClinPGx/CPIC/PGRN 2025

The ClinPGx/CPIC 2025 Meeting will be held in collaboration with the PGRN in Missoula, Montana, September 8-11, 2025.

Introducing the DDRx Mobile App!

Check out DDRx - the new mobile app for genotype-based prescribing guidance from PharmGKB/ClinPGx.